Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
Titel:
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
Auteur:
McGarvey, Lorcan P Birring, Surinder S Morice, Alyn H Dicpinigaitis, Peter V Pavord, Ian D Schelfhout, Jonathan Nguyen, Allison Martin Li, Qing Tzontcheva, Anjela Iskold, Beata Green, Stuart A Rosa, Carmen La Muccino, David R Smith, Jaclyn A
Verschenen in:
Lancet
Paginering:
Jaargang 399 () nr. 10328 pagina's 909-923
Jaar:
2022
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. All rights reserved.